P2RX4通过介导的PI3K/AKT激活和免疫重塑促进肝细胞癌的进展
Jianrong Wang1,2, Yanmei Gu1,2, Ze Niu1,2
1THE SECOND HOSPITAL & CLINICAL MEDICAL SCHOOL, Lanzhou University, Lanzhou, Gansu, 730000, China.
World journal of surgical oncology
|October 10, 2025
概括
一个离子通道的P2RX4通过增加的流入和抑制抗瘤免疫力来促进肝细胞癌 (HCC) 的进展. 准P2RX4可能为HCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 往往呈现于晚期,限制了治疗选择,并导致不良结果.
- P2RX4是一种ATP导离子通道,影响细胞增殖,炎症和免疫力,但其在HCC中的作用尚不清楚.
研究的目的:
- 研究P2RX4在肝细胞癌 (HCC) 的表达,功能和免疫影响.
主要方法:
- 通过TCGA-LIHC和TIMER2.0数据库分析P2RX4表达,通过140个HCC组织的免疫组织化学验证.
- 在体外研究中评估了P2RX4沉默后的细胞增殖,入侵和殖民地形成.
- 进行了转录基因组测序,离子定量 (ICP-OES) 和西部抹杀 (PI3K/AKT通路).
主要成果:
- 在HCC组织中增加P2RX4表达与晚期和不良预后相关.
- 抑制P2RX4降低了瘤细胞的增殖,入侵,细胞内和AKT酸化.
- 高P2RX4水平与M0巨细胞/Tregs增加,单细胞减少和免疫治疗反应减弱有关.
结论:
- 通过流入,PI3K/AKT激活和抑制抗瘤免疫力,P2RX4可能会推动HCC的进展.
- P2RX4显示出作为HCC的预后生物标志物和治疗点的潜力.
- 需要进一步的体内研究来证实这些发现.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
IP3/DAG Signaling Pathway
14.3K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
14.3K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
Amplifying Signals via Second Messengers
8.4K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
8.4K


